1) Hepatocellular carcinoma
肝细胞癌
1.
Mcl-1 gene and hepatocellular carcinoma;
Mcl-1基因与肝细胞癌
2.
Expression of Livin and Smac in primary hepatocellular carcinoma tissue;
原发性肝细胞癌组织中Livin和Smac蛋白的表达
3.
Reversal of multidrug resistance of hepatocellular carcinoma by siRNA/mdr1;
RNA干扰逆转肝细胞癌多药耐药
2) HCC
肝细胞癌
1.
The Research on PTEN and ICAM-1 with HCC;
PTEN基因和细胞间粘附分子-1与肝细胞癌的研究
2.
Analysis and function prediction of ESTs differentially expressed in HCC by Bioinformatics strategy;
肝细胞癌中差异表达EST的生物信息学分析和功能预测
3.
Analysis of ESTs differentially expressed in HCC by Bioinformatics strategy;
肝细胞癌中差异表达的表达序列标签的生物信息学分析
3) Hepatocellular carcinoma(HCC)
肝细胞癌
1.
[Purpose] To study the expression and significance of the vascular endothelial growth factor(VEGF) and matrix metalloproteinase 2(MMP-2) in hepatocellular carcinoma(HCC) tissues,and to explore their correlation with angiogenesis of HCC.
[目的]研究肝细胞癌(HCC)组织中血管内皮生长因子(VEGF)及基质金属蛋白酶-2(MMP-2)蛋白的表达及其临床意义,并探讨其与血管生成的关系。
2.
To investigate the relationship between survivin and Bcl - xl gene expression in human hepatocellular carcinoma(HCC).
探讨生存素(Survivin)基因在肝细胞癌中的表达与凋亡抑制基因bcl-xl的相关性。
3.
Objective:To study the status and significances of bcl 2,p53 and p21 gene expression in hepatocellular carcinoma(HCC).
目的 :了解抑凋亡基因 bcl- 2、抑癌基因 p5 3和癌基因 p2 1基因蛋白在肝细胞癌 (HCC)中的表达状况及意义。
4) Hepatocelluar carcinoma
肝细胞癌
1.
The Role of Epithelial-mesenchymal Transition Induced by Twist Protein in Vasculogenesis in Hepatocelluar Carcinoma;
Twist诱导上皮间充质转变在肝细胞癌血管生成中的作用
2.
Of the 52 cases,29 were diagnosed as hepatoblastoma, 12 were hepatocelluar carcinoma.
8%)<6岁,而12例肝细胞癌中5例(41。
3.
Objective To study the relationship between the expression of cyclooxygenase-2(COX-2) and apoptosis in hepatocelluar carcinoma(HCC),and to investigate its possible mechanisms.
目的探讨肝细胞癌(HCC)中环氧化酶-2(COX-2)的表达与细胞凋亡的关系及其可能的机制。
5) hepatocellular carcinoma (HCC)
肝细胞癌
1.
Objective: To investigate the expression of p53 protein in hepatocellular carcinoma (HCC) and its relationship with clinical pathological feature and prognosis of HCC and alpha-fetopritein (AFP), hepatitis B virus (HBV) infection in HCC.
目的:探讨p53与肝细胞癌临床病理学特征和患者预后、AFP、HBV感染之间的关系。
2.
Orthotopic liver transplantation (OLT) is the most useful therapeutic option for patients with hepatocellular carcinoma (HCC), because it removes the multifocal potential of HCC in many patients that limits the success and applicability of resection, and also treats the underlying liver disease.
原位肝移植是治疗肝细胞癌最有效的方法，因为肝移植除去了肝癌发生的根源，并且可以达到根治术的最大范围。
3.
Although hepatocellular carcinoma (HCC) arises from a combination of mutations in oncogenes and tumour suppressor genes including p53, the exact mechanism by which p53 mediates anticancer activity and the relationship between p53 and HCC are not well understood.
目的p53是迄今为止发现的突变率最高、涉及范围最广的抑癌基因之一,在肝细胞癌(以下简称肝癌)的动物模型中也发现,细胞癌变的早期即伴有p53功能缺失或突变。
6) hepatoma cell
肝癌细胞
1.
Expression and significance of CD147 and MMP-9 in hepatoma cell line SMMC-7721;
肝癌细胞株SMMC-7721中CD147和MMP-9的表达及意义
2.
Effects of ferromagnetic fluid hyperthermia induced by an alternative magnetic field on hepatoma cell HepG2 in vitro;
铁磁流体联合交变磁场对人肝癌细胞HepG2的影响
3.
Study on apoptosis of human hepatoma cell line hepG2 induced by Paeoniflorin;
芍药甙诱导人肝癌细胞系HepG2凋亡的研究
补充资料：肝细胞癌假包膜性生长
肝细胞癌假包膜性生长
hepatocellular carcinoma pseudocapsular growth pattern
为置换性生长中的一种特殊方式。肿瘤常呈膨胀性生长压迫周围非瘤组织。网状纤维的假包膜沿瘤界聚集而成。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条